The use of myeloperoxidase as a risk marker for atherosclerosis

被引：26

作者：

Nambi V. ^{[1
]}

机构：

[1] Section of Cardiology, Baylor College of Medicine, Houston, TX 77030

来源：

Current Atherosclerosis Reports | 2005年 / 7卷 / 2期

关键词：

Acute Coronary Syndrome; Endothelial Dysfunction; Vulnerable Plaque; Arterioscler Thromb Vasc Biol; Major Adverse Cardiovascular Event;

D O I：

10.1007/s11883-005-0035-z

中图分类号：

学科分类号：

摘要：

The mechanisms of atheroma formation and their ensuing complications and methods by which these can be detected have been the focus of several in vitro, in vivo, and clinical studies. Myeloperoxidase (MPO) is a microbicidal hemoprotein that serves as a part of the neutrophils' armory in host defense. However, the oxidation products generated by MPO have now been shown to be related to various stages of atheroma development. MPO and its oxidant products have been shown to be capable of modifying low-density lipoprotein cholesterol and to be enriched in human atheromas and rupture-prone plaques. Clinical studies have suggested an association between levels of MPO and the presence of coronary artery disease and endothelial dysfunction, and have shown a possible additional role to troponin in patients with chest pain. Copyright © 2005 by Current Science Inc.

引用

页码：127 / 131

页数：4

共 44 条

[1]

Falk E., Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi, Br. Heart J., 50, pp. 127-134, (1983)

[2]

Friedman M., Van den Bovenkamp G.J., Role of thrombus in plaque formation in human diseased coronary artery, Br. J. Exp. Pathol., 47, pp. 550-557, (1966)

[3]

Davies M.J., Thomas A.C., Plaque fissuring: The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, Br. Heart J., 53, pp. 363-373, (1985)

[4]

Willerson J.T., Campbell W.B., Winniford M.D., Et al., Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms, Am. J. Cardiol., 54, pp. 1349-1354, (1984)

[5]

Naghavi M., Libby P., Falk E., Et al., From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part I, Circulation, 108, pp. 1664-1672, (2003)

[6]

Naghavi M., Libby P., Falk E., Et al., From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessment strategies: Part II, Circulation, 108, pp. 1772-1778, (2003)

[7]

Ross R., Atherosclerosis - An inflammatory disease, N. Engl. J. Med., 340, pp. 115-126, (1999)

[8]

Klebanoff S.J., A peroxidase mediated antimicrobial system in leukocytes, J. Clin. Invest., 46, (1967)

[9]

Daugherty A., Dunn J.L., Rateri D.L., Et al., Myeloperoxidase, a catalyst for lipoprotein oxidation is expressed in human atherosclerotic lesions, J. Clin. Invest., 94, pp. 437-444, (1994)

[10]

Nauseef W.M., Malech H.L., Analysis of the peptide subunits of human neutrophil myeloperoxidase, Blood, 67, pp. 1504-1507, (1986)

← 1 2 3 4 5 →